Why it was recalled
Subpotent drug
Product description
Mucus Relief D, Guaifenesin Pseudoephedrine HCl ER Tablets, 600 mg/60mg, packaged in 36-count blister pack packed into cartons, Distributed by: Walgreen Co., 200 Wilmot Rd., Deerfield, IL 60015, Made in India, NDC 0363-164-3
Lot numbers, UPCs & expiration codes
Lot #: AT2102065A, AT2102065B, Exp 04/2023.
Where it was sold
USA Nationwide
What to do if you have this product
- Compare the lot number and expiration date on your package with the codes above.
- Don't stop taking a prescription medicine on your own. Call your pharmacist or doctor; they can confirm whether your supply is affected and arrange a replacement.
- If you have symptoms you think are related, contact your doctor. In an emergency call 911.
- Report side effects to FDA MedWatch at 1-800-FDA-1088.
Recall details
- Recall number
- D-0388-2022
- Classification
- Class III
- Status
- Terminated
- Recall initiated
- Jan 10, 2022
- FDA report date
- Jan 26, 2022
- Quantity
- 18336 cartons
- Recall type
- Voluntary: Firm initiated
- Recalling firm
- Dr. Reddy's Laboratories, Inc.
Original FDA data
Every field from FDA enforcement report D-0388-2022, exactly as published.
Show all FDA fields
- City
- Princeton
- State
- NJ
- Status
- Terminated
- Country
- United States
- Event ID
- 89388
- Address
- 107 College Rd E
- Code information
- Lot #: AT2102065A, AT2102065B, Exp 04/2023.
- Postal code
- 08540-6623
- Report date
- Jan 26, 2022
- Product type
- Drugs
- Recall number
- D-0388-2022
- Classification
- Class III
- Recalling firm
- Dr. Reddy's Laboratories, Inc.
- Product quantity
- 18336 cartons
- Termination date
- Mar 29, 2024
- Reason for recall
- Subpotent drug
- Voluntary / mandated
- Voluntary: Firm initiated
- Product description
- Mucus Relief D, Guaifenesin Pseudoephedrine HCl ER Tablets, 600 mg/60mg, packaged in 36-count blister pack packed into cartons, Distributed by: Walgreen Co., 200 Wilmot Rd., Deerfield, IL 60015, Made in India, NDC 0363-164-3
- Distribution pattern
- USA Nationwide
- Recall initiation date
- Jan 10, 2022
- Initial firm notification
- Letter
- Center classification date
- Jan 19, 2022